breast-cancer.oncotypedx.comAbout the Oncoytpe DX Breast Recurrence Score® | Oncotype IQ®
breast-cancer.oncotypedx.com Profile
breast-cancer.oncotypedx.com
Maindomain:oncotypedx.com
Title:About the Oncoytpe DX Breast Recurrence Score® | Oncotype IQ®
Description:The standard of care for genomic-based, individualized risk assessment for early-stage invasive breast cancer to predict the likely benefit of chemotherapy.
Discover breast-cancer.oncotypedx.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
breast-cancer.oncotypedx.com Information
Website / Domain: |
breast-cancer.oncotypedx.com |
HomePage size: | 299.592 KB |
Page Load Time: | 0.035656 Seconds |
Website IP Address: |
216.143.232.105 |
Isp Server: |
iLoop Mobile |
breast-cancer.oncotypedx.com Ip Information
Ip Country: |
United States |
City Name: |
San Jose |
Latitude: |
37.333698272705 |
Longitude: |
-121.88929748535 |
breast-cancer.oncotypedx.com Keywords accounting
breast-cancer.oncotypedx.com Httpheader
Cache-Control: no-cache, no-store |
Pragma: no-cache |
Content-Type: text/html; charset=utf-8 |
Expires: -1 |
Last-Modified: Thu, 30 Jul 2020 22:10:06 GMT |
Server: Microsoft-IIS/8.5 |
X-FRAME-OPTIONS: SAMEORIGIN |
Vary: Accept-Encoding |
Content-Encoding: gzip |
Date: Sun, 02 Aug 2020 05:25:28 GMT |
Transfer-Encoding: chunked |
Connection: keep-alive, Transfer-Encoding |
breast-cancer.oncotypedx.com Meta Info
content="" id="metaKeywords" name="keywords"/ |
content="The standard of care for genomic-based, individualized risk assessment for early-stage invasive breast cancer to predict the likely benefit of chemotherapy. " id="metaDescription" name="description"/ |
content="index,follow" id="ctl01_metaRobots" name="robots"/ |
content="text/html; charset=utf-8" http-equiv="Content-Type"/ |
content="C#" name="CODE_LANGUAGE"/ |
content="JavaScript" name="vs_defaultClientScript"/ |
content="http://schemas.microsoft.com/intellisense/ie5" name="vs_targetSchema"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
content="https://www.oncotypeiq.com/en-US/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test" property="og:url" |
content="About the Oncoytpe DX Breast Recurrence Score® | Oncotype IQ®" property="og:title"/ |
content="The standard of care for genomic-based, individualized risk assessment for early-stage invasive breast cancer to predict the likely benefit of chemotherapy. " property="og:description"/ |
content="" property="og:image"/ |
216.143.232.105 Domains
breast-cancer.oncotypedx.com Similar Website
Domain |
WebSite Title |
breast-cancer.oncotypedx.com | About the Oncoytpe DX Breast Recurrence Score® | Oncotype IQ® |
ewbc.com | Elizabeth Wende Breast Care | Breast Imaging in Rochester, NY |
educareinc.com | EduCare - breast cancer treatment book, breast health navigator, patient products & support, diagnos |
breastcenter.ucla.edu | UCLA Breast Health: Top Breast Cancer Treatment, Specialists, Mastectomy, Reconstruction - UCLA Brea |
thebreastcancersite.greatergood.com | The Breast Cancer Site | Click to Fund Breast Cancer Research |
thebreastcancersite.com | The Breast Cancer Site | Click to Fund Breast Cancer Research |
secure.avon39.org | Breast Cancer Crusade, Fight Against Breast Cancer with AVON |
info.avon39.org | Breast Cancer Crusade, Fight Against Breast Cancer with AVON |
breastcancer.cancersummit.org | Breast Cancer Conferences | Breast Cancer Summit 2020 | Cancer Conferences | Singapore | Asia | Euro |
bcaction.org | Breast Cancer Action |
archive.bcaction.org | Breast Cancer Action |
asistershope.org | A Sister's Hope for Breast Cancer Research |
ww3.komen.org | Breast Cancer Foundation | Susan G. Komen® |
nqmbc.org | Home - National Consortium of Breast Centers |
forum.bearchive.com | Breast Expansion Archive Forum - Index |
breast-cancer.oncotypedx.com Traffic Sources Chart
breast-cancer.oncotypedx.com Alexa Rank History Chart
breast-cancer.oncotypedx.com Html To Plain Text
× Title Description × × × Toggle navigation United States Brazil Canada - English Canada - Français Deutschland France Ελλάδα Ireland Latin America Spain United Kingdom 日本 See All Physician Login Healthcare Professionals Patients & Caregivers About Oncotype IQ Contact Us Tissue-Based Assays Oncotype DX Breast DCIS Score About the test Clinical evidence How does it compare to other genomic tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications Available Now For a refined risk estimate of local recurrence Learn More Learn More Oncotype DX Breast Recurrence Score About the test Clinical evidence How does it compare to other genomic tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications Prospective Outcomes: TAILORx Primary study group results were presented at ASCO 2018. Read Full Text Read Full Text Oncotype DX Genomic Prostate Score About Oncotype DX GPS The genomic approach Evidence GPS works How does it compare to other tests? Is your patient eligible? Insurance coverage & financial assistance Order the test Interpreting GPS results How to talk to your patient about Oncotype DX GPS Publications Clinical Utility: Active Surveillance In a large clinical data set GPS increased AS utilzation Read Full Text Read Full Text Oncotype DX Colon Recurrence Score About the test Evidence it works How does it compare to other tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications Genomics Infographic Help Stage II colon cancer patients understand the power of genomics Download Download Liquid-Based Assays Oncotype DX AR-V7 Nucleus Detect About the test Why nuclear detection Clinical evidence Is your patient eligible Insurance coverage and financial assistance How to order the test Interpreting the results Perspectives in mCRPC Publications Clinical Comparator Trial Nuclear-specific vs. nuclear-agnostic AR-V7 testing Read Full Text Read Full Text Introducing Our Newest Test Learn More Learn More Breast Cancer Stage 0 - DCIS About the test Eligibility and testing Insurance coverage & financial assistance Oncotype DX Results: What to expect Hear from our patients FAQs and useful videos Do You Really Need Radiation Therapy? Your Oncotype DX score can help you decide. Stage I-IIIA - Invasive About the test Eligibility and testing Insurance coverage & financial assistance Oncotype DX Results: What to expect Hear from our patients FAQs and useful videos Do You Really Need Chemotherapy? Oncotype DX has helped thousands of women find out. Colon Cancer Stage II-IIIB About the test Eligibility and testing Insurance coverage and financial assistance Oncotype DX Results: What to expect FAQs Real Patients. Real Stories. When Dan's Colon Recurrence Score came back low, he decided against chemotherapy. Prostate Cancer Early Stage Why Oncotype DX GPS? Clinical eligibility and testing Insurance coverage & financial assistance Oncotype DX GPS Results: Interpreting the results Hear from our patients FAQs and useful videos News Coverage Read what the Wall Street Journal is saying about the Oncotype DX Genomic Prostate Score test. Read the Article Read the Article Metastatic About the test Eligibility & testing Insurance coverage & financial assistance AR-V7 Nucleus Detect results: What to expect FAQs Get Our Patient Brochure Download Download Our Award-Winning App Helps You Stay Organized Get Free App Get Free App Home Healthcare Professionals Healthcare Professionals Breast Cancer Oncotype DX Breast DCIS Score Oncotype DX Breast DCIS Score About the test Clinical evidence How does it compare to other genomic tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications Oncotype DX Breast Recurrence Score Oncotype DX Breast Recurrence Score About the test Clinical evidence How does it compare to other genomic tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications Prostate Cancer Oncotype DX Genomic Prostate Score Oncotype DX Genomic Prostate Score About Oncotype DX GPS The genomic approach Evidence GPS works How does it compare to other tests? Is your patient eligible? Insurance coverage & financial assistance Order the test Interpreting GPS results How to talk to your patient about Oncotype DX GPS Publications Oncotype DX AR-V7 Nucleus Detect Oncotype DX AR-V7 Nucleus Detect About the test Why nuclear detection Clinical evidence Is your patient eligible Insurance coverage and financial assistance How to order the test Interpreting the results Perspectives in mCRPC Publications Colon Cancer Oncotype DX Colon Recurrence Score Oncotype DX Colon Recurrence Score About the test Evidence it works How does it compare to other tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications Patients & Caregivers Patients & Caregivers Breast Cancer Stage 0 - DCIS Stage 0 - DCIS About the test Eligibility and testing Insurance coverage & financial assistance Oncotype DX Results: What to expect Hear from our patients FAQs and useful videos Stage I-IIIA - Invasive Stage I-IIIA - Invasive About the test Eligibility and testing Insurance coverage & financial assistance Oncotype DX Results: What to expect Hear from our patients FAQs and useful videos Prostate Cancer Early Stage Early Stage Why Oncotype DX GPS? Clinical eligibility and testing Insurance coverage & financial assistance Oncotype DX GPS Results: Interpreting the results Hear from our patients FAQs and useful videos Metastatic Metastatic About the test Eligibility & testing Insurance coverage & financial assistance AR-V7 Nucleus Detect results: What to expect FAQs Colon Cancer Stage II-IIIB Stage II-IIIB About the test Eligibility and testing Insurance coverage and financial assistance Oncotype DX Results: What to expect FAQs About Oncotype IQ Contact Us Resources Resources Videos Brochures Online Ordering Sign-up United States Brazil Canada - English Canada - Français Deutschland France Ελλάδα Ireland Latin America Spain United Kingdom 日本 See All Physician Login Healthcare Professionals > Oncotype DX Breast Recurrence Score Topics About the test Clinical evidence How does it compare to other genomic tests? Is your patient eligible? Insurance coverage & financial assistance How to order a test Interpreting the results Case studies Publications About the Oncotype DX Breast Recurrence Score ® Test Share Testing Core Biopsy Specimens - READ DETAILS The COVID-19 pandemic has had a life-altering effect on the lives of the general population, but most notably health care providers and those with a diagnosis of cancer. We are all aware that in order to optimize provider, hospital, and clinic delivery of care, decisions are being made that are resulting in the postponement of both screening and diagnostic oncology services as well as elective surgery. Our Oncotype DX® tests remain readily available and our laboratory continues to operate. Core biopsies are the initial diagnostic procedure of choice for breast masses identified by physical exam or by imaging techniques. The Oncotype DX test process was optimized to require only small amounts of tumor tissue and can be performed on a core biopsy of the breast cancer in lieu of the final resection specimen. Guidance from the COVID-19 Pandemic Breast Cancer Consortium* references that a low-risk Recurrence Score® result from a core biopsy may be used to treat patients with Stage 1 or 2 disease, including N+ (1-3), with endocrine therapy alone when delaying surgery. a View t...
breast-cancer.oncotypedx.com Whois
"domain_name": "ONCOTYPEDX.COM",
"registrar": "Register.com, Inc.",
"whois_server": "whois.register.com",
"referral_url": null,
"updated_date": "2018-06-05 20:10:14",
"creation_date": "2003-09-24 17:49:05",
"expiration_date": "2027-09-24 17:49:05",
"name_servers": [
"UDNS1.ULTRADNS.NET",
"UDNS2.ULTRADNS.NET"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": "abuse@web.com",
"dnssec": "unsigned",
"name": null,
"org": null,
"address": null,
"city": null,
"state": null,
"zipcode": null,
"country": null